-+ 0.00%
-+ 0.00%
-+ 0.00%

Does Nutrien (TSX:NTR) Pairing Higher Potash Volumes With Buybacks Refine Its Core Investment Story?

Simply Wall St·08/09/2026 12:21:16
语音播报
  • Nutrien Ltd. recently reported second-quarter 2026 results, with sales rising to US$10,812 million and net income of US$1,214 million, while also declaring a quarterly dividend of US$0.55 per share payable on October 16, 2026.
  • The company paired this performance with increased full-year 2026 volume guidance for Potash and detailed reliability-driven volume expectations for Nitrogen and Phosphate, alongside completing a US$261 million buyback of 3,732,920 shares.
  • We’ll now examine how Nutrien’s stronger sales and higher Potash volume guidance may influence its existing investment narrative and longer-term outlook.

Find 14 companies with promising cash flow potential yet trading below their fair value.

Nutrien Investment Narrative Recap

To own Nutrien, you need to believe demand for core nutrients like potash and nitrogen will support steady volumes while the company keeps improving efficiency and capital returns. The latest quarter’s modestly higher sales and largely flat earnings do not materially change that picture in the short term. However, the raised potash volume guidance sharpens focus on fertilizer pricing as the key near term catalyst, while regulatory and technology driven shifts in fertilizer use remain the most important long term risk.

The most relevant update here is Nutrien’s 2026 guidance, particularly the higher potash sales volume range of 14.2 million to 14.8 million tonnes. This ties directly into the volume and efficiency story many investors are watching, especially as nitrogen and phosphate guidance also depends on reliability improvements. Together with the US$261 million share buyback, these announcements put more weight on how well Nutrien can convert higher volumes into consistent earnings and cash generation.

Yet, against these encouraging volume signals, investors should be aware that tightening environmental rules and shifting grower preferences could still materially reshape Nutrien’s long term fertilizer demand profile...

Read the full narrative on Nutrien (it's free!)

Nutrien’s narrative projects $27.3 billion revenue and $2.2 billion earnings by 2029. This assumes fairly flat yearly revenue growth and a $0.2 billion earnings decrease from $2.4 billion today.

Uncover how Nutrien's forecasts yield a CA$110.93 fair value, a 23% upside to its current price.

Exploring Other Perspectives

TSX:NTR 1-Year Stock Price Chart
TSX:NTR 1-Year Stock Price Chart

While consensus sees volume growth and cost savings as key supports, the most pessimistic analysts were assuming roughly flat revenue near US$26.1 billion and earnings around US$1.7 billion, so this latest guidance could either ease or reinforce their concerns about margins and long term fertilizer demand.

Explore 6 other fair value estimates on Nutrien - why the stock might be worth just CA$97.46!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

Ready To Venture Into Other Investment Styles?

Our top stock finds are flying under the radar-for now. Get in early:

  • Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.
  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • Uncover the next big thing with 11 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.